Topic: drug shortage

Here is some other vaccine news of note for the week.

Mylan, Pfizer and the FDA notified U.S. healthcare providers of a potential problem with some EpiPens which can delay treatment.

Manufacturing issues at a CMO and a missed forecast by Merck have led to a shortage of some of its Parkinson’s disease drug Sinemet.

A hospital-backed group, Civica Rx intends to manufacture or contract the production of 14 drugs that are in chronic supply.

Privately held Kaléo has a supply of epinephrine auto injectors and is making sure the public knows its version is available.

Dogs and cats are now feeling the pain of Pfizer’s manufacturing problems that have contributed to a nationwide shortage of injectable opioids.

Adult-dose EpiPens are once again in short supply in Canada as manufacturing issues persist at a Pfizer plant that produces them for Mylan.

Hikma is looking to ease the U.S. shortage of hydromorphone as the FDA gave its OK to Terumo BCT to shore up short supplies of anticoagulant solution.

The FDA may create a list of “essential drugs” and financial incentives to drugmakers that manufacture them as it grapples with drug shortages.

Two U.S. senators urged GlaxoSmithKline to do more about the ongoing shortage of Shingrix.